From: Impact of the COVID-19 pandemic on management of children and adolescents with Type 1 diabetes
Estimate | Standard Error | P | |
---|---|---|---|
Intercept | 7.71 | 0.14 | < 0.0001 |
Age,y | 0.05 | 0.01 | < 0.0001 |
Gender | |||
Male | 0.00 | ||
Female | 0.11 | 0.06 | 0.06 |
Year | |||
2019 | 0.00 | ||
2020 | 0.04 | 0.06 | NS |
Insurance | |||
Commercial | 0.00 | ||
Non-commercial | 0.62 | 0.07 | < 0.0001 |
Race/ethnicity | |||
White | 0.00 | ||
Black | 1.31 | 0.09 | < 0.0001 |
Hispanic | 0.41 | 0.08 | < 0.0001 |
Other | -0.10 | 0.12 | NS |
CGM use | |||
Yes | 0.00 | ||
No | 0.87 | 0.07 | < 0.0001 |